This study revealed the FSH-positive related molecular characteristics—especially its invasion-related molecular characteristics—in FSH-positive NFPAs, which provided the scientific data for effectively prognostic assessment and personalized treatment of FSH-positive NFPA patients. Here, BRD2 is linked to non-functioning pituitary adenoma.